Flagship explainer

How WEST PHARMACEUTICAL SERVICES, INC. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$3.1B · 100%Cost of revenue$2.0B · 64%Gross profit$1.1B · 36%Operating income$585M · 19%Income before tax$601M · 20%Income tax$122M · 4%Net income$494M · 16%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$3.1B100%
Cost of revenue$2.0B64%
$1.1B36%
$585M19%
Income before tax$601M20%
Income tax$122M4%
$494M16%
Source: · event Dec 31, 2025 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full WEST PHARMACEUTICAL SERVICES, INC. analysis at Buy Like Buffett

WST income explainer — Buy Like Buffett · Buy Like Buffett